Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab pharmacokinetics in moderate to severe ulcerative colitis
NL-OMON44551Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of golimumab in autoimmune colitis, sponsored by Amsterdam University Medical Center. Primary endpoint: Golimumab drug level. Started Sep 2014; status: active, not recruiting.
02
Drugs
golimumab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON44551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44551.